Standout Papers

Randomized Phase III Study of Capecitabine Plus Oxaliplatin Compared With Fluorouracil/Folinic A... 2008 2026 2014 2020 636
  1. Randomized Phase III Study of Capecitabine Plus Oxaliplatin Compared With Fluorouracil/Folinic Acid Plus Oxaliplatin As First-Line Therapy for Metastatic Colorectal Cancer (2008)
    Jim Cassidy, Stephen Clarke et al. Journal of Clinical Oncology
  2. Phase III Study Comparing Gemcitabine Plus Cetuximab Versus Gemcitabine in Patients With Advanced Pancreatic Adenocarcinoma: Southwest Oncology Group–Directed Intergroup Trial S0205 (2010)
    Philip A. Philip, Jacqueline Benedetti et al. Journal of Clinical Oncology

Immediate Impact

1 by Nobel laureates 8 from Science/Nature 69 standout
Sub-graph 1 of 23

Citing Papers

Polymeric Nanoparticles for Drug Delivery
2024 Standout
Trifluridine–Tipiracil and Bevacizumab in Refractory Metastatic Colorectal Cancer
2023 Standout
2 intermediate papers

Works of Ralph Wong being referenced

Randomized Phase III Study of Capecitabine Plus Oxaliplatin Compared With Fluorouracil/Folinic Acid Plus Oxaliplatin As First-Line Therapy for Metastatic Colorectal Cancer
2008 Standout

Author Peers

Author Last Decade Papers Cites
Ralph Wong 392 1247 218 320 8 1.4k
Alice Chen 603 1280 234 213 14 1.7k
B. Mirtsching 452 1124 128 284 24 1.3k
Lloyd K. Everson 375 967 232 193 30 1.4k
Barbara J. Maclean 243 1001 533 165 13 1.4k
Felix Chu 524 625 248 235 19 1.6k
Priyanka Shivdasani 647 642 249 344 11 1.3k
Karen Rittweger 359 947 269 105 17 1.3k
Yukinori Murata 375 827 223 170 22 1.3k
Anja H. Loos 596 1521 324 199 16 1.9k
Matias Riihimäki 795 1333 437 287 12 2.1k

All Works

Loading papers...

Rankless by CCL
2026